Australian vaccine preventable disease epidemiological review series: mumps 2008-2012
DOI:
https://doi.org/10.33321/cdi.2015.39.2Keywords:
mumps, disease surveillance, immunisationAbstract
In 2007, Australia recorded the highest notification rate (2.8 per 100,000) for mumps since it became notifiable, with outbreaks in Western Australia and the Northern Territory. Of particular concern was the number of cases seen in vaccinated individuals. The aim of this study was to review subsequent epidemiological data. Notification, hospitalisation and mortality data from the National Notifiable Diseases Surveillance System, the National Hospital Morbidity Database and Australian Bureau of Statistics (ABS) respectively, from 2008 to 2012 for notifications and 2008 to 2011 for hospitalisations and deaths, were analysed by age, year and jurisdiction. ABS population data were used to calculate rates. National mumps notification rates decreased from 1.3 per 100,000 in 2008 to 0.4 per 100,000 in 2010, but then increased to 0.9 per 100,000 in 2012, predominantly due to increased notifications in New South Wales (1.4 per 100,000). Hospitalisation rates remained stable at 0.4 per 100,000 over the 2008–2011 period. The median age of notified cases was 30 years and for hospitalisations, 27 years. The highest rate of notifications and hospitalisations was in the 25–34 years age group. Completeness of vaccination status ranged from 16% to 39%. The increasing trend in mumps notifications needs to be closely monitored. Improved data quality, in particular on vaccination status, is needed to inform the monitoring of vaccine effectiveness. In March 2014 the World Health Organization certified that Australia had achieved measles elimination. Greater availability of case history (vaccination status and place of acquisition) and genotyping data would facilitate an assessment of Australia’s progress in relation to mumps elimination. Commun Dis Intell 2015;39(1):E10–E18.
Downloads
References
Litman N, Baum SG. Mumps virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th edn. USA: Churchill Livingstone Elsevier; 2010. p. 2201–2206.
Hviid A, Rubin S, Muhlemann K. Mumps. [Review]. Lancet 2008;371(9616):932–944.
Mumps. In: Heymann D, ed. Control of Communicable Diseases Manual. 19th edn. Washington: American Public Health Association; 2008. p. 431–434.
National Centre for Immunisation Research and Surveillance. Significant events in measles, mumps and rubella vaccination practice in Australia, 2013. Accessed on 3 December 2013. This document was available from: http://www.ncirs.edu.au/immunisation/history/Measles-mumps-rubella-history-July-2013.pdf at the time of writing.
Heywood AE, Gidding H, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ 2009;87(1):64–71.
Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign. BMC Public Health 2007;7:99.
Gidding H, Wood J, MacIntyre CR, Kelly HA, Lambert SB, Gilbert GL, et al. Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine 2007;25(18):3574–3580.
Centers for Disease Control and Prevention. Current trends Mumps – United States, 1980–1983. MMWR Morb Mortal Wkly Rep 1983;32(42):545–547.
Public Health England. In: Salisbury D, Ramsay M, Noakes K, editors Immunisation against infectious disease: the green book. 3rd edn. London: TSO (The Stationery Office) under licence from the Department of Health; 2013.
McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002;26(Suppl):1–111.
Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Commun Dis Intell 2010;34(Suppl):S1–S167.
Brotherton J, Wang H, Schaffer A, Quinn H, Menzies R, Hull B, et al. Vaccine preventable disease and vaccination coverage in Australia 2003 to 2005. Commun Dis Intell 2007;31(Suppl):S1–S152.
Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjun R, et al. Mumps outbreaks across England and Wales in 2004. BMJ 2005;330(7500):1119–1120.
Centers for Disease Control and Prevention. Update: multistate outbreak of mumps-United States, 1 January–2 May 2006. MMWR Morb Mortal Wkly Rep 2006;55(20):559–563.
Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009;27(44):2186–6195.
World Health Organisation. Mumps reported cases. 2013. Accessed on 19 March 2014. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencemumps.html
Brotherton J, McIntyre P, Puech M, Wang H, Gidding H, Hull B, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2001 to 2002. Commun Dis Intell 2004;28(2):S36–S40.
Communicable Diseases Network Australia. Surveillance case definitions for the Australian National Notifiable Diseases Surveillance System. 2004. Accessed on 18 October 2013. Available from: http://www.health.gov.au/casedefinitions
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2011: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2013;37(4):E313–E393.
Australian Institute of Health and Welfare. Indigenous identification in hospital separations data: quality report. Cat. no. HSE 85 . Health Services Series no. 35 Canberra: Australian Institute of Health and Welfare; 2010.
Australian Bureau of Statistics. Australian Demographic Statistics. Released on 20 June 2013. Canberra; Australian Bureau of Statistics: cat no. 3101.0. 2013. [online] Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202013?OpenDocument
Aratchige PE, McIntyre PB, Quinn H, Gilbert GL. Recent increases in mumps incidence in Australia: the “forgotten” age group in the 1998 Australian Measles Control Campaign. Med J Aust 2008;189(8):434–437.
Health Protection Branch, Department of Health Victoria. Surveillance of notifiable infectious diseases in Victoria 2009. Melbourne; 2011.
Department of Health Victoria. Communicable disease surveillance, Victoria, October–December 2012. Victorian Infectious Diseases Bulletin 2013;16(1):27–47.
Department of Health Victoria. Communicable disease surveillance in Victoria, January–March 2011. Victorian Infect Dis Bull 2011;14(2):57-75.
Department of Health Victoria. Communicable disease surveillance, Victoria, October–December 2011. Victorian Infect Dis Bull 2012;15(1):21–39.
Department of Health Victoria. A cluster of mumps cases in Melbourne, Victoria linked to international transmission. Victorian Infect Dis Bull 2012;15(2):42–48.
Coleman K, Markey P, Krause V. Mumps in the NT. The Northern Territory Disease Control Bulletin 2008;15(4):11–17.
Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. Canberra: Australian Government Department of Health and Ageing; 2013.
Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps outbreak in orthodox Jewish communities in the US. N Engl J Med 2012;367(18):1704–1713.
Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control-Guam 2009–2010. Pediatr Infect Dis J 2013;32(4):374–380.
Zipprich J, Murray EL, Winter K, Kong D, Harriman K, Preas C, et al. Mumps outbreak on a university campus-California, 2011. MMWR Morb Mortal Wkly Rep 2012;61(48):986–989.
Dayan GH, Quinlisk P, Parker AA, Barskey AE, Harris ML, Schwartz JMH, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008;358(15):1580–1589.
Bangor-Jones RD, Dowse GK, Gele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009;191(7):398–401.
Dayan GH, Rubin S. Mumps outbreaks in vaccinated population: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis 2008;47(11):1458–1467.
Rubin S, Link MA, Sauder C, Zhang C, Ngo L, Rima BK, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2011;86(1):615–620.
Plotkin SA, Rubin S. Chapter 20 Mumps vaccine. In: Plotkin SA, Oreinstein WA, Offit PA, editors. Vaccines. 5th edn. Philadelphia, PA: Saunders Elsevier; 2008.
Deeks S, Lim GH, Simpson MA, Gagne L, Gubbay J, Kristjanson E, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. Can Med Assoc J 2011;183(9):1014–1020.
Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. Br Med J 2005;330(7500):1132–1135.
Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008;26(29–30):3601–3607.
Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, et al. Epidemic of mumps among vaccinated persons, the Netherlands, 2009–2012. Emerg Infect Dis 2014;20(4):643–648.
Rubin S, Plotkin SA. Ch. 22 Mumps vaccine. In: Plotkin SA, Oreinstein WA, Offit PA, editors. Vaccines. 6th edn. China: Elsevier Saunders; 2013.
World Health Organisation Western Pacific Region. Four Western Pacific countries and areas are the first in their Region to be measles-free. 2014. Accessed on 22 March 2014. Available from: http://www.wpro.who.int/mediacentre/releases/2014/20140320/en/
Song N, Gao Z, Hueston L, Gilbert GL, MacIntyre CR, Quinn H, et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine 2012;30(27):4073–4078.
Fine P, Mulholland K. Chapter 71: Community Immunity. In: Plotkin SA, Oreinstein WA, Offit PA, editors. Vaccines. 6th edn. China: Elsevier Saunders; 2013.
Hull B, Dey A, Menzies R, Brotherton J, McIntyre P. Immunisation coverage annual report, 2011. Commun Dis Intell 2014;37(4):E291–E312.
Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008;46(8):1172–1180.
Peltola H, Jokinen S, Paunio M, Hovi T, Davidkin I. Measles, mumps and rubella in Finland: 25 years of a nationwide elimination programme. Lancet 2008;8(12):796–803.
Davidkin I, Kontio M, Paunio M, Peltola H. MMR vaccination and disease elimination: the Finnish experience. Expert Rev Vaccines 2010;9(9):1045–1053.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2015 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
